[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:chordoma":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":68,"states":69},"Chordoma",9,7,[8,16,22,28,35,42,48,54,61],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06794645","Pembrolizumab and Pemetrexed for Progressive Chordoma",[12],"Phase 2","RECRUITING","2026-08-26T02:16:27.227548Z","2026-05-05T02:43:27.626136Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT03886311","Talimogene Laherparepvec, Nivolumab and Trabectedin for Sarcoma",[12],"2026-08-26T02:17:06.985283Z","2026-05-05T02:43:28.539009Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":26,"content_modified":27},"NCT04040205","Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration",[12],"2026-08-26T02:18:07.037408Z","2026-05-05T02:43:28.417090Z",{"nct_id":29,"title":30,"phases":31,"status":13,"updated_at":33,"content_modified":34},"NCT06625190","Alpha\u002FBeta T and B Cell Depletion With Zoledronic Acid for Solid Tumors",[32],"Phase 1\u002FPhase 2","2026-08-26T02:19:04.543908Z","2026-07-05T03:45:20.453806Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":40,"content_modified":41},"NCT06906900","A Phase I Study of the NovoTTF-200M and Novo TTF-200A Systems for the Treatment of Refractory Spinal Metastasis",[39],"Phase 1","2026-08-26T02:18:51.009190Z","2026-05-05T02:43:27.318476Z",{"nct_id":43,"title":44,"phases":45,"status":13,"updated_at":46,"content_modified":47},"NCT03910465","Children and Adults With Chordoma",[],"2026-08-26T02:18:29.369233Z","2026-05-13T02:55:06.179028Z",{"nct_id":49,"title":50,"phases":51,"status":13,"updated_at":52,"content_modified":53},"NCT05033288","Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the Bone",[],"2026-08-26T02:17:15.156099Z","2026-05-13T02:55:06.280317Z",{"nct_id":55,"title":56,"phases":57,"status":58,"updated_at":59,"content_modified":60},"NCT07005297","Clinical Genetics Branch Eligibility Screening Survey",[],"NOT_YET_RECRUITING","2026-08-26T02:16:01.910993Z","2026-05-13T02:55:06.607645Z",{"nct_id":62,"title":63,"phases":64,"status":65,"updated_at":66,"content_modified":67},"NCT04087902","Long-Term Longitudinal QoL in Patients Undergoing EEA",[],"ACTIVE_NOT_RECRUITING","2026-08-03T03:02:05.931134Z","2026-05-13T02:55:06.184138Z",[],[70],{"state":71,"count":72,"slug":73},"Florida",3,"florida"]